Profilo
Michael J.
Dawson is currently the Chief of Staff at Centinela Hospital Medical Center.
Previously, he served as the Chief Medical Officer at Leading Biosciences, Inc. and Palisade Bio, Inc. from 2021 to 2022.
He holds a doctorate degree from the University of Southern California and a graduate degree from the University of California San Diego.
Posizioni attive di Michael Dawson
| Società | Posizione | Inizio |
|---|---|---|
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Ufficiale delle Risorse Umane | - |
Precedenti posizioni note di Michael Dawson
| Società | Posizione | Fine |
|---|---|---|
| PALISADE BIO, INC. | Direttore Tecnico/Scientifico/R&S | 11/10/2022 |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Direttore Tecnico/Scientifico/R&S | - |
Formazione di Michael Dawson
Esperienze
Posizioni ricoperte
Attive
Inattive
Società nel listino
Aziende private
Relazioni
Relazioni di 1° grado
Aziende connesse in 1º grado
Uomo
Donna
Amministratori
Dirigenti
Società collegate
| Aziende private | 5 |
|---|---|
University of Southern California
University of Southern California Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Centinela Hospital Medical Center
Centinela Hospital Medical Center Hospital/Nursing ManagementHealth Services Operates an acute care hospital | Health Services |
University of California San Diego
University of California San Diego Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Leading Biosciences, Inc.
Leading Biosciences, Inc. Miscellaneous Commercial ServicesCommercial Services Develops therapeutic and diagnostic approaches for obesity and diabetes | Commercial Services |
Palisade Bio, Inc.
Palisade Bio, Inc. Pharmaceuticals: MajorHealth Technology Operates as a late stage biopharmaceutical company which develops therapies for acute and chronic gastrointestinal disorders | Health Technology |
















